Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified-release versus immediate-release methylphenidate effects on sleep in adults with ADHD
IRCT20201101049214N1Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Anxiety at the beginning and end of each treatment period, Daily activity at the beginning and end of each treatment period and 2 more. Started Nov 2020; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20201101049214N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201101049214N1.